Learning Objectives:

Jiho Han, MD

1. Serial assessment of hemodynamics in cardiogenic shock.

2. Use of serial biomarkers in cardiogenic shock.

Jonathan Lattell, MD

1. Define advanced heart failure and clinical significance.

2. Define the role of right heart catheterization in patients with advanced heart failure.

3. Explain the significance of sedation use and effects on hemodynamic measurements.

Joseph Weber, MD

1. Patients with high acuity presentations for Impella (i.e. cardiogenic shock and cardiac arrest) and those requiring
      additional MCS (ECMO but not IABP) are at greater risk for BARC3a+ bleeding.

2. Need for device replacement/repositioning, time on support as well as elevated INR, lactic acid, and Cr* portend a higher
       risk of bleeding.

3. Significant hemorrhage is associated with short and long-term mortality.